Mitochondrial diseases are a diverse group of disorders caused by dysfunction in mitochondria, the energy-generating organelles of cells. These disorders result from mutations in either nuclear or mitochondrial DNA and can be classified as primary (genetic origin) or secondary (environmentally induced). Due to their systemic impact, mitochondrial dysfunction leads to a wide range of clinical symptoms varying from tissue type and patient age. This review aims to provide a comprehensive overview of mitochondrial diseases, focusing on their classification, pathophysiology, diagnostic challenges and emerging therapeutic strategies. Current diagnostic approaches face limitations due to the complexity and heterogeneity of mitochondrial disorders. Recent evidence highlights the potential of phytochemicals such as polyphenols, flavonoids, alkaloids and terpenoids in modulating mitochondrial function. These natural compounds can enhance mitochondrial biogenesis, reduce oxidative stress and improve cellular energy metabolism. Phytochemicals represent a promising therapeutic avenue for mitigating mitochondrial dysfunction. However, further research is needed to validate their efficacy and develop standardized treatment protocols. An improved understanding of the molecular mechanisms involved in mitochondrial pathology will aid in developing more targeted diagnostic and therapeutic strategies. Graphical abstract
Ramya, R. Prabhu, Megha, K. B., Reshma, S. et al. Mitochondrial disease management through phytochemical interventions. // Molecular and Cellular Biochemistry. – 2025. – DOI: 10.1007/s11010-025-05360-6. – URL: http://link.springer.com/openurl/fulltext?id=doi:10.1007/s11010-025-05360-6
Ramya, R. Prabhu, Megha, K. B, Reshma, S, Krishnan, M. J. Ajai, Amir, S, Sharma, Rashmi, Mohanan, & P. V (2025). Mitochondrial disease management through phytochemical interventions. Molecular and Cellular Biochemistry. https://doi.org/10.1007/s11010-025-05360-6
Ramya, et al. “Mitochondrial disease management through phytochemical interventions.” Molecular and Cellular Biochemistry, 2025. doi:10.1007/s11010-025-05360-6.
@article{Ramya2025,
title = {Mitochondrial disease management through phytochemical interventions},
author = {Ramya and Prabhu, R. and Megha and B., K. and Reshma and S. and Krishnan and Ajai, M. J. and Amir and S. and Sharma and Rashmi and Mohanan and V., P.},
journal = {Molecular and Cellular Biochemistry},
year = {2025},
doi = {10.1007/s11010-025-05360-6},
url = {http://link.springer.com/openurl/fulltext?id=doi:10.1007/s11010-025-05360-6}
}
Large extracellular vesicles (lEVs) are heterogeneous structures with sizes that exceed 200 nm. Unlike small extracellular vesicles, which originate from either the endosomal system or the plasma membrane, most lEVs stem directly from...
Chaperone-mediated autophagy (CMA), the first-described selective lysosomal degradation pathway, is distinguished from other degradative pathways by the unique mechanism by which substrates reach the lysosomal lumen: CMA relies on a...
This Review focuses on the choice between homologous recombination and non-homologous end joining in DNA double-strand break repair. The antagonistic roles of 53BP1 and BRCA1–BARD1, the contribution of RNA–DNA hybrids and implications...
A 2010 paper identified PRDM9 as the sequence-specific regulator of meiotic recombination hotspots, showing it co-evolves with its rapidly changing binding motifs.
Genome editing is maturing from a one-size-fits-all system into a highly specialized ecosystem that includes a dizzying array of tools. In this Comment, we discuss the current and future use of Cas-induced homology-directed repair for...